Natco Pharma seeks approval for Covid drug candidate Molnupiravir

NATCO is hoping that CDSCO would give emergency approval of this drug based on 'compassionate use' for patients.The company is ready to launch the product this month if approval is given

from mint - News https://ift.tt/3gDvJGd
https://ift.tt/eA8V8J